Reuters logo
Biogen posts 18.7 pct jump in quarterly profit
October 24, 2017 / 11:09 AM / a month ago

Biogen posts 18.7 pct jump in quarterly profit

Oct 24 (Reuters) - U.S. drugmaker Biogen Inc on Tuesday reported an 18.7 percent rise in quarterly profit, driven by strong demand for its recently approved spinal muscular atrophy drug, Spinraza.

Total revenue rose to $3.08 billion from $2.96 billion.

Net income attributable to Biogen rose to $1.23 billion, or $5.79 per share, in the third quarter ended Sept. 30, compared with $1.03 billion, or $4.71 per share, a year earlier. (Reporting by Akankshita Mukhopadhyay and Manas Mishra in Bengaluru; Editing by Martina D‘Couto)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below